InterPAD - DETAILS

glimepiride, 93479-97-1, Amaryl, cis-Glimepiride, Amarel, Glimepirid, Glimepirida, Glimepiridum, 684286-46-2, Hoe-490, Glimepride, HOE 490, Glimepiride, cis-, Glimepiride Impurity A, CHEBI:5383, 1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea, 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide, Endial, 261361-60-8, NSC-759809, 24T6XIR2MZ, DTXSID5040675, MFCD00878417, 6KY687524K, NCGC00016960-03, Glimepiridum [Latin], Roname, Glimepirida [Spanish], CAS-93479-97-1, Glista OD, 1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-(2-(4-(((((4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-, trans-, 3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, Ristomycin Monosulfate (90%), DTXCID3020675, Glymepirid, Glorion, Glemax, Glimer, Solosa, Ristocetin Sulfate; Ristomycin Sulfate, 1-[[4-[2-[[(3-Ethyl-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]-3-(cis-4-methylcyclohexyl)urea (cis-Glimepiride), 3-Ethyl-4-methyl-N-(4-(N-((rel-(1r,4r)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-{2-[4-({[(4-methylcyclohexyl)carbamoyl]amino}sulfonyl)phenyl]ethyl}-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, SMR000466368, SL-NH2 Trifluoroacetic Acid Salt (1:2), Amaryl (TN), CCRIS 7083, SR-05000001508, UNII-24T6XIR2MZ, boxamide, BRN 5365754, gimepiride, Niddaryl, Sugral, HOE490, UNII-6KY687524K, Glimepiride,(S), Glimepiride [USAN:USP:INN:BAN], Glimepiride; 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl] 2-oxo-1H-pyrrole-1-carboxamide; Amaryl; Glimperide; HOE 490; trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl] 2-oxo-1H-pyrrole-1-carboxamide, Amaryl, Glista OD, Glimepiride- Bio-X, CPD000466368, GLIMEPIRIDE [MI], Prestwick0_000651, Prestwick1_000651, Prestwick2_000651, Prestwick3_000651, GLIMEPIRIDE [INN], GLIMEPIRIDE [JAN], GLIMEPIRIDE [USAN], GLIMEPIRIDE [VANDF], CHEMBL1481, GLIMEPIRIDE [MART.], Oprea1_382896, SCHEMBL16084, SCHEMBL16086, BSPBio_000681, GLIMEPIRIDE [USP-RS], GLIMEPIRIDE [WHO-DD], GLIMEPIRIDE CIS-ISOMER, MLS000759495, MLS001076674, MLS001401419, MLS003915622, MLS006011260, SPBio_002602, GLIMEPIRIDE [EMA EPAR], BPBio1_000751, CHEMBL149223, GTPL6820, SCHEMBL8738802, Glimepiride (JP17/USP/INN), SCHEMBL14371714, SCHEMBL14965363, SCHEMBL26496475, CHEBI:92609, DTXSID20861130, GLIMEPIRIDE [ORANGE BOOK], Glimepiride for system suitability, GLIMEPIRIDE [EP MONOGRAPH], GLIMEPIRIDE [USP IMPURITY], HMS1570C03, HMS2052L03, HMS2090K18, HMS2097C03, HMS2235L07, HMS3269A09, HMS3372O07, HMS3394L03, HMS3413K06, HMS3654F17, HMS3677K06, HMS3714C03, Pharmakon1600-01504915, GLIMEPIRIDE [USP MONOGRAPH], BCP05331, DUETACT COMPONENT GLIMEPIRIDE, HY-B0104, Tox21_110713, AC-476, BDBM50237590, NSC759809, NSC813217, s1344, STL451059, STL453194, AKOS015894919, AKOS015969663, Glimepiride, >=98% (HPLC), solid, Tox21_110713_1, AB07644, BCP9000728, CCG-101156, CS-1844, DB00222, KS-5238, NC00406, NSC 759809, NSC-813217, NCGC00016960-01, NCGC00016960-02, NCGC00016960-04, NCGC00016960-05, NCGC00016960-07, NCGC00161404-01, NCGC00161404-02, NCGC00181757-01, NCGC00371061-02, NCGC00371061-06, 1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea, 1H-Pyrrole-1-carboxamide, 2,5-dihydro-3-ethyl-4-methyl-N-(2-(4-(((((4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-, trans-, 3-ethyl-4-methyl-n-(4-(n-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro, BG164507, SMR001550123, Glimepiride 100 microg/mL in Acetonitrile, AB00513874, CS-0165191, FT-0626713, FT-0668978, G0395, GLIMEPIRIDE IMPURITY A [EP IMPURITY], NS00004860, SW196369-4, C07669, D00593, AB00513874-06, AB00513874-08, AB00513874-09, AB00513874_10, AB00513874_11, A844609, A899888, EN300-19873446, Q425027, Q-201158, SR-05000001508-1, SR-05000001508-2, SR-05000001508-3, BRD-K34776109-001-03-4, BRD-K42693031-001-01-8, Q27253874, Z1501475009, Glimepiride, British Pharmacopoeia (BP) Reference Standard, Glimepiride, European Pharmacopoeia (EP) Reference Standard, 3-ethyl-4-methyl-N-(4-(N-((1r,4r)-4-methylcyclohexylcarbamoyl), Glimepiride, United States Pharmacopeia (USP) Reference Standard, sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, Glimepiride for system suitability, European Pharmacopoeia (EP) Reference Standard, ;cis-3-Ethyl-2,5-dihydro-4-Methyl-N-[2-[4-[[[[(cis-4-Methylcyclohexyl)aMino]carbonyl]aMino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxaMide, 1-((4-(2-(((3-ETHYL-4-METHYL-2-OXO-2,3-DIHYDRO-1H-PYRROL-1-YL)CARBONYL)AMINO)ETHYL)PHENYL)SULFONYL)-3-(CIS-4-METHYLCYCLOHEXYL)UREA, 1H-PYRROLE-1-CARBOXAMIDE, 3-ETHYL-2,5-DIHYDRO-4-METHYL-N-(2-(4-(((((CIS-4-METHYLCYCLOHEXYL)AMINO)CARBONYL)AMINO)SULFONYL)PHENYL)ETHYL)-2-OXO-, 1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans- 4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-, 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-2-oxo-N-(2-{4-[({[(1r,4r)-4-methylcyclohexyl]carbamoyl}amino)sulfonyl]phenyl}ethyl)-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-(4-(N-(((1r,4r)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-(4-(N-(((1s,4s)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide? (Glimepiride Impurity pound(c), 3-ETHYL-4-METHYL-N-(4-(N-((1R,4R)-4-METHYLCYCLOHEXYLCARBAMOYL)SULFAMOYL)PHENETHYL)-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE, 3-ethyl-4-methyl-N-(4-(N-((trans-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-[2-(4-{[(4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-[2-(4-{[(cis-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-car, 3-ethyl-4-methyl-N-[2-(4-{[(cis-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-car boxamide, 3-Ethyl-4-Methyl-N-[2-(4-{[(Cis-4-Methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-Oxo-2,5-Dihydro-1h-Pyrrole-1-Carboxamide, N'-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-N-(4-methylcyclohexyl)carbamimidic acid, N-(4-ethyl-3-methyl-5-oxo-2H-pyrrol-1-yl)-3-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]propanamide;GLIMEPIRIDE, N-[4-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)-ethyl]-benzenesulfonyl]-N'-4-methylcyclohexylurea, trans-1-(4-(2-(3-ethyl-4-Me-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenylsulfonyl)-3-(4-methylcyclohexyl)urea, trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide, Trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide

Name	Glimepiride
PubChem CID	3476
Molecular Weight	490.6g/mol
Synonyms	glimepiride, 93479-97-1, Amaryl, cis-Glimepiride, Amarel, Glimepirid, Glimepirida, Glimepiridum, 684286-46-2, Hoe-490, Glimepride, HOE 490, Glimepiride, cis-, Glimepiride Impurity A, CHEBI:5383, 1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea, 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide, Endial, 261361-60-8, NSC-759809, 24T6XIR2MZ, DTXSID5040675, MFCD00878417, 6KY687524K, NCGC00016960-03, Glimepiridum [Latin], Roname, Glimepirida [Spanish], CAS-93479-97-1, Glista OD, 1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-(2-(4-(((((4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-, trans-, 3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, Ristomycin Monosulfate (90%), DTXCID3020675, Glymepirid, Glorion, Glemax, Glimer, Solosa, Ristocetin Sulfate; Ristomycin Sulfate, 1-[[4-[2-[[(3-Ethyl-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]-3-(cis-4-methylcyclohexyl)urea (cis-Glimepiride), 3-Ethyl-4-methyl-N-(4-(N-((rel-(1r,4r)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-{2-[4-({[(4-methylcyclohexyl)carbamoyl]amino}sulfonyl)phenyl]ethyl}-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, SMR000466368, SL-NH2 Trifluoroacetic Acid Salt (1:2), Amaryl (TN), CCRIS 7083, SR-05000001508, UNII-24T6XIR2MZ, boxamide, BRN 5365754, gimepiride, Niddaryl, Sugral, HOE490, UNII-6KY687524K, Glimepiride,(S), Glimepiride [USAN:USP:INN:BAN], Glimepiride; 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl] 2-oxo-1H-pyrrole-1-carboxamide; Amaryl; Glimperide; HOE 490; trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl] 2-oxo-1H-pyrrole-1-carboxamide, Amaryl, Glista OD, Glimepiride- Bio-X, CPD000466368, GLIMEPIRIDE [MI], Prestwick0_000651, Prestwick1_000651, Prestwick2_000651, Prestwick3_000651, GLIMEPIRIDE [INN], GLIMEPIRIDE [JAN], GLIMEPIRIDE [USAN], GLIMEPIRIDE [VANDF], CHEMBL1481, GLIMEPIRIDE [MART.], Oprea1_382896, SCHEMBL16084, SCHEMBL16086, BSPBio_000681, GLIMEPIRIDE [USP-RS], GLIMEPIRIDE [WHO-DD], GLIMEPIRIDE CIS-ISOMER, MLS000759495, MLS001076674, MLS001401419, MLS003915622, MLS006011260, SPBio_002602, GLIMEPIRIDE [EMA EPAR], BPBio1_000751, CHEMBL149223, GTPL6820, SCHEMBL8738802, Glimepiride (JP17/USP/INN), SCHEMBL14371714, SCHEMBL14965363, SCHEMBL26496475, CHEBI:92609, DTXSID20861130, GLIMEPIRIDE [ORANGE BOOK], Glimepiride for system suitability, GLIMEPIRIDE [EP MONOGRAPH], GLIMEPIRIDE [USP IMPURITY], HMS1570C03, HMS2052L03, HMS2090K18, HMS2097C03, HMS2235L07, HMS3269A09, HMS3372O07, HMS3394L03, HMS3413K06, HMS3654F17, HMS3677K06, HMS3714C03, Pharmakon1600-01504915, GLIMEPIRIDE [USP MONOGRAPH], BCP05331, DUETACT COMPONENT GLIMEPIRIDE, HY-B0104, Tox21_110713, AC-476, BDBM50237590, NSC759809, NSC813217, s1344, STL451059, STL453194, AKOS015894919, AKOS015969663, Glimepiride, >=98% (HPLC), solid, Tox21_110713_1, AB07644, BCP9000728, CCG-101156, CS-1844, DB00222, KS-5238, NC00406, NSC 759809, NSC-813217, NCGC00016960-01, NCGC00016960-02, NCGC00016960-04, NCGC00016960-05, NCGC00016960-07, NCGC00161404-01, NCGC00161404-02, NCGC00181757-01, NCGC00371061-02, NCGC00371061-06, 1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea, 1H-Pyrrole-1-carboxamide, 2,5-dihydro-3-ethyl-4-methyl-N-(2-(4-(((((4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-, trans-, 3-ethyl-4-methyl-n-(4-(n-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro, BG164507, SMR001550123, Glimepiride 100 microg/mL in Acetonitrile, AB00513874, CS-0165191, FT-0626713, FT-0668978, G0395, GLIMEPIRIDE IMPURITY A [EP IMPURITY], NS00004860, SW196369-4, C07669, D00593, AB00513874-06, AB00513874-08, AB00513874-09, AB00513874_10, AB00513874_11, A844609, A899888, EN300-19873446, Q425027, Q-201158, SR-05000001508-1, SR-05000001508-2, SR-05000001508-3, BRD-K34776109-001-03-4, BRD-K42693031-001-01-8, Q27253874, Z1501475009, Glimepiride, British Pharmacopoeia (BP) Reference Standard, Glimepiride, European Pharmacopoeia (EP) Reference Standard, 3-ethyl-4-methyl-N-(4-(N-((1r,4r)-4-methylcyclohexylcarbamoyl), Glimepiride, United States Pharmacopeia (USP) Reference Standard, sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, Glimepiride for system suitability, European Pharmacopoeia (EP) Reference Standard, ;cis-3-Ethyl-2,5-dihydro-4-Methyl-N-[2-[4-[[[[(cis-4-Methylcyclohexyl)aMino]carbonyl]aMino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxaMide, 1-((4-(2-(((3-ETHYL-4-METHYL-2-OXO-2,3-DIHYDRO-1H-PYRROL-1-YL)CARBONYL)AMINO)ETHYL)PHENYL)SULFONYL)-3-(CIS-4-METHYLCYCLOHEXYL)UREA, 1H-PYRROLE-1-CARBOXAMIDE, 3-ETHYL-2,5-DIHYDRO-4-METHYL-N-(2-(4-(((((CIS-4-METHYLCYCLOHEXYL)AMINO)CARBONYL)AMINO)SULFONYL)PHENYL)ETHYL)-2-OXO-, 1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans- 4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-, 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-2-oxo-N-(2-{4-[({[(1r,4r)-4-methylcyclohexyl]carbamoyl}amino)sulfonyl]phenyl}ethyl)-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-(4-(N-(((1r,4r)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-(4-(N-(((1s,4s)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide? (Glimepiride Impurity pound(c), 3-ETHYL-4-METHYL-N-(4-(N-((1R,4R)-4-METHYLCYCLOHEXYLCARBAMOYL)SULFAMOYL)PHENETHYL)-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE, 3-ethyl-4-methyl-N-(4-(N-((trans-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-[2-(4-{[(4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-[2-(4-{[(cis-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-car, 3-ethyl-4-methyl-N-[2-(4-{[(cis-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-car boxamide, 3-Ethyl-4-Methyl-N-[2-(4-{[(Cis-4-Methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-Oxo-2,5-Dihydro-1h-Pyrrole-1-Carboxamide, N'-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-N-(4-methylcyclohexyl)carbamimidic acid, N-(4-ethyl-3-methyl-5-oxo-2H-pyrrol-1-yl)-3-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]propanamide;GLIMEPIRIDE, N-[4-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)-ethyl]-benzenesulfonyl]-N'-4-methylcyclohexylurea, trans-1-(4-(2-(3-ethyl-4-Me-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenylsulfonyl)-3-(4-methylcyclohexyl)urea, trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide, Trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide
Drug Type	Small molecule
Formula	C₂₄H₃₄N₄O₅S
SMILES	CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C
InChI	1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)
InChIKey	WIGIZIANZCJQQY-UHFFFAOYSA-N
CAS Number	261361-60-8
ChEMBL ID	CHEMBL149223
ChEBI ID	CHEBI:5383
TTD ID	D0B2GI
Toxicity	Organism	Test Type	Route(Dose)
	rat	LD50	intraperitoneal(165 mg/kg)
	mouse	LD50	intraperitoneal(254 mg/kg)
	rat	LD50	oral(322 mg/kg)
Structure			Download 2D MOL 3D MOL

Pair Name	Niacinamide, Glimepiride
Partner Name	Niacinamide
Result	The efficacy of insulin and other antidiabetic agents may be diminished by certain drugs, including atypical antipsychotics, corticosteroids, diuretics, estrogens, gonadotropin-releasing hormone agonists, human growth hormone, phenothiazines, progestins, protease inhibitors, sympathomimetic amines, thyroid hormones, L-asparaginase, alpelisib, copanlisib, danazol, diazoxide, isoniazid, megestrol, omacetaxine, phenytoin, tagraxofusp, temsirolimus, as well as pharmacologic dosages of nicotinic acid and adrenocorticotropic agents. These drugs may interfere with blood glucose control because they can cause hyperglycemia, glucose intolerance, new-onset diabetes mellitus, and/or exacerbation of preexisting diabetes.